Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Luna Innovations Incorporated (LUNA)

  • Company Report
  • Jan. 05, 2023, 16:35 UTC
  • 45

Luna to Present at Needham Growth Conference

Comment Full text

Nektar Therapeutics (NKTR)

  • Company Report
  • Jan. 05, 2023, 13:51 UTC
  • 41

New Form 10-Q for Nektar Therapeutics

Comment Full text

Vericel Corporation (VCEL)

  • Company Report
  • Jan. 04, 2023, 16:40 UTC
  • 47

Vericel to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023

Comment Full text

Cytokinetics Inc (CYTK)

  • Company Report
  • Jan. 04, 2023, 00:05 UTC
  • 46

Cytokinetics to Participate in the 41st Annual J.P. Morgan Healthcare Conference

Comment Full text

VolitionRX Limited (VNRX)

  • Company Report
  • Jan. 03, 2023, 16:15 UTC
  • 43

Book a meeting with Volition - JPM 2023

Comment Full text

Vericel Corporation (VCEL)

  • Company Report
  • Dec. 29, 2022, 21:50 UTC
  • 48

Vericel Announces FDA Approval of NexoBrid for the Treatment of Severe Thermal Burns in Adults

Comment Full text

MAIA Biotechnology Inc. (MAIA)

  • Company Report
  • Dec. 24, 2022, 15:27 UTC
  • 40

Happy Holidays from MAIA Biotechnology

Comment Full text

Citius Pharmaceuticals Inc. (CTXR)

  • Company Report
  • Dec. 23, 2022, 00:45 UTC
  • 44

Citius Pharmaceuticals, Inc. - 2022 Annual Report

Comment Full text

Citius Pharmaceuticals Inc. (CTXR)

  • Company Report
  • Dec. 23, 2022, 00:45 UTC
  • 43

Citius Pharmaceuticals, Inc. - Fourth Quarter 2022

Comment Full text

QuantumSi Inc (QSI)

  • Company Report
  • Dec. 23, 2022, 00:25 UTC
  • 47

New Form 4 for Quantum-Si Incorporated

Comment Full text
  • Previous
  • 36
  • 37
  • 38
  • 39
  • 40
  • Next

Search

News categories

  • Technical Exchange News(9316)
  • Event(407)
  • SEC News(151044)
  • FDA Approval(8679)
  • Company Report(721)
  • Business News(103713)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin